In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Magnesii oxidum ponderosum Drug Master File in Korea (Magnesii oxidum ponderosum KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Magnesii oxidum ponderosum. The MFDS reviews the Magnesii oxidum ponderosum KDMF as part of the drug registration process and uses the information provided in the Magnesii oxidum ponderosum KDMF to evaluate the safety and efficacy of the drug.
After submitting a Magnesii oxidum ponderosum KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Magnesii oxidum ponderosum API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Magnesii oxidum ponderosum suppliers with KDMF on PharmaCompass.